Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inherited Platelet Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07575308
What this trial is testing

HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB

Who this might be right for
Von Willebrand Disease (VWD)Heavy Menstrual Bleeding (HMB)
Alnylam Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT01410227
What this trial is testing

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Who this might be right for
Von Willebrand Disease
Baxalta now part of Shire 49
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Not applicableStudy completedNCT05345561
What this trial is testing

Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Who this might be right for
Fetal and Neonatal Alloimmune Thrombocytopenia
Rallybio 14,390
Not applicableStudy completedNCT01602419
What this trial is testing

Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease

Who this might be right for
Von Willebrand Disease
Octapharma 120
Not applicableNot Yet RecruitingNCT07410130
What this trial is testing

Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate

Who this might be right for
Von Willebrand Disease (VWD)Inherited Bleeding Disorders in ChildrenPediatric Hemostatic Disorders
Assiut University 25
Not applicableStudy completedNCT01876745
What this trial is testing

Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in Japan

Who this might be right for
Congenital Bleeding DisorderGlanzmann's Disease
Novo Nordisk A/S 4
Large-scale testing (Phase 3)Study completedNCT04052698
What this trial is testing

Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD

Who this might be right for
Von Willebrand Diseases
Octapharma 43
Not applicableStudy completedNCT00697320
What this trial is testing

Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

Who this might be right for
Congenital Bleeding DisorderCongenital FVII DeficiencyGlanzmann's Disease+2 more
Novo Nordisk A/S 64
Early research (Phase 1)Study completedNCT00816660
What this trial is testing

Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease

Who this might be right for
Von Willebrand Disease
Baxalta now part of Shire 32
Not applicableNot Yet RecruitingNCT06873672
What this trial is testing

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

Who this might be right for
Quality of Life (QOL)Patient-Reported Outcome Measures (PROMs)Pneumonia Childhood+3 more
RenJi Hospital 360
Testing effectiveness (Phase 2)Study completedNCT01375608
What this trial is testing

Decitabine for High-Risk Sickle Cell Disease

Who this might be right for
NeutropeniaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 10
Not applicableLooking for participantsNCT06610201
What this trial is testing

Bleeding and Treatment in Participants With Von Willebrand Disease

Who this might be right for
Von Willebrand Disease (VWD)Von Willebrand Disease (VWD), Type 1Von Willebrand Disease (VWD), Type 2+4 more
Hemab ApS 200
Testing effectiveness (Phase 2)UnknownNCT04371939
What this trial is testing

Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Not applicableWithdrawnNCT01276561
What this trial is testing

Single Incision Versus Standard Laparoscopic Splenectomy

Who this might be right for
Hereditary SpherocytosisIdiopathic Thrombocytopenic Purpura
Children's Mercy Hospital Kansas City
Post-approval studies (Phase 4)Study completedNCT02552576
What this trial is testing

Study of Voncento® in Subjects With Von Willebrand Disease

Who this might be right for
Von Willebrand Disease
CSL Behring 26
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT04350749
What this trial is testing

The Use of Platelet-rich Fibrin (PRF) Membranes in Lateral Alveolar Ridge Augmentation When Jaw Bone is Missing Before Dental Implant Installation. A Study Comparing an Autogenous Bone Block Graft Covered Either by a (PRF) Membrane (Test) or Bone Substitute and a Barrier Membrane (Control)

Who this might be right for
Tooth-loss
University of Aarhus 27
Testing effectiveness (Phase 2)Study completedNCT00305708
What this trial is testing

Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

Who this might be right for
Congenital Amegakaryocytic ThrombocytopeniaDiamond-blackfan AnemiaFanconi Anemia+3 more
University of California, San Francisco 40
Next Page